Pzena Investment Management
TAK icon

Pzena Investment Management’s Takeda Pharmaceutical TAK Stock Holding History

Pzena Investment Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$606K Buy
37,820
+9,460
+33% +$157K ﹤0.01% 142
2026
Q1 		$525K Buy
28,360
+7,733
+37% +$136K ﹤0.01% 144
2025
Q4 		$322K Buy
+20,627
New +$295K ﹤0.01% 146

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Pzena Investment Management's TAK Position: Q2 2026 in Review

Pzena Investment Management increased its Takeda Pharmaceutical (TAK) stake by 33% in Q2 2026, buying an estimated $157K and bringing the position to 37,820 shares worth $606K. The position accounts for ﹤0.01% of the portfolio, ranked #142.

Pzena Investment Management first reported a position in TAK in Q4 2025 and has held it in 3 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Pzena Investment Management held 37,820 shares of Takeda Pharmaceutical worth $606K as of Q2 2026.
  • Pzena Investment Management bought 9,460 Takeda Pharmaceutical shares in Q2 2026, an estimated $157K.
  • Takeda Pharmaceutical made up ﹤0.01% of Pzena Investment Management's portfolio in Q2 2026, its #142 holding.
  • Pzena Investment Management first reported a position in Takeda Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Pzena Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.